“…Brain levels of manganese become elevated in several neurodegenerative (e.g., Alzheimer’s disease and Parkinson’s disease) and metabolic (e.g., hepatic encephalopathy) diseases and in manganese toxicity (Lai et al, 1999; Lai et al, 2000). Of relevance to the regulation of brain GS is the finding that significant levels of the elevated Mn are likely detected in astrocytes, because these cells are known to accumulate Mn avidly (Lai et al, 1999; Lai et al, 2000; Wedler et al, 1994). Consequently, the elevation of astrocytic Mn levels may exert modulatory effects on GS activity and flux and ultimately on glutamate-glutamine and glutamate-GABA-glutamine cycling in those disease states (Chowdhury et al, 2007; Jain et al, 2011; Lai et al, 1999; Lai et al, 2000; Sibson et al, 2001; Wedler et al, 1994).…”